Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Kara Rice

1PUBLICATIONS

8CO-AUTHORS

Autoimmunity

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Oct 25, 2024

Efficacy and Safety of Ravulizumab in IgA Nephropathy: A Phase 2 Randomized Double-Blind Placebo-Controlled Trial.

Richard Lafayette, James Tumlin, Roberta Fenoglio

Pageof 1

Frequent Collaborators

1 joint publications

Richard Lafayette

1 joint publications

Jessica Kaufeld

1 joint publications

Miguel Ángel Pérez Valdivia

1 joint publications

Shih-Han Susan Huang

1 joint publications

Eric Alamartine

1 joint publications

Sung Gyun Kim

1 joint publications

Katherine Garlo

1 joint publications

Jonathan Barratt

Frequent Collaborators

1 joint publications

Richard Lafayette

1 joint publications

Jessica Kaufeld

1 joint publications

Miguel Ángel Pérez Valdivia

1 joint publications

Shih-Han Susan Huang

Top Related Videos

Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation <em>In Vivo</em> and Decreasing Galactose-Deficient IgA1 Production <em>In Vitro</em>

Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation <em>In Vivo</em> and Decreasing Galactose-Deficient IgA1 Production <em>In Vitro</em>

Published on : Oct 13, 2023

See more related videos

Top Related Videos

Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation <em>In Vivo</em> and Decreasing Galactose-Deficient IgA1 Production <em>In Vitro</em>

Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation <em>In Vivo</em> and Decreasing Galactose-Deficient IgA1 Production <em>In Vitro</em>

Published on : Oct 13, 2023

See more related videos